This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Hypersomnolence

Authoring team

Excessive daytime sleepiness (EDS) is best described as an urge to sleep during daytime hours

  • this is a common problem
    • occurs for at least three days a week in 4-20% of the population
    • affects quality of life, workplace performance, and has safety implications, for example, when driving

Prompt diagnosis is important because effective therapeutic strategies are available for many causes of excessive daytime sleepiness. In some cases treatment may not only improve quality of life but also reduce mortality.

Essentials:

  • key to accurate diagnosis is differentiating excessive daytime sleepiness (EDS) from symptoms of fatigue or being “tired all the time”

  • the Epworth Sleepiness Scale (ESS) score is a useful way to assess and classify EDS
    • ESS >10 indicates EDS and >17 indicates severe EDS

  • commonest causes of EDS include:
    • obstructive sleep apnoea, periodic limb movement syndrome, narcolepsy, and circadian rhythms

  • treatment of obstructive sleep apnoea
    • reduces excessive daytime sleepiness
    • improves neuropsychological function
    • reduces blood pressure

  • referral is indicated for patients with EDS
    • for assessment, including overnight sleep study

Reference:

  • Drug and Therapeutics Bulletin (2004); 42(7): 52-6.
  • Brown J, Makker KM. An approach to excessive daytime sleepiness in adults. BMJ 2020;368:m1047


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.